Flexpharma Inc. (FLKS) Stock Price, Quote, News and Overview
NASDAQ:FLKS - Nasdaq -
FLKS Quote, Performance and Key Statistics
0.6068
+0 (+0.23%)
The current stock price of FLKS is 0.6068 null. In the past month the price increased by 25.11%. In the past year, price decreased by -30.65%.
About FLKS
Company Profile
Flex Pharma, Inc. is a biotechnology company. The Company is involved in developing treatments for nocturnal leg cramps and spasms associated with severe neuromuscular conditions. Flex Pharma, Inc. is headquartered in Boston, Massachusetts.
Company Info
Flexpharma Inc.
31 St. James Avenue 6thFloor
Boston MA 02116
CEO: William McVicar
Phone: 617-874-1821
Flexpharma Inc. / FLKS FAQ
What is the stock price of Flexpharma Inc. today?
The current stock price of FLKS is 0.6068 null. The price increased by 0.23% in the last trading session.
What is the ticker symbol for Flexpharma Inc. stock?
The exchange symbol of Flexpharma Inc. is FLKS and it is listed on the Nasdaq exchange.
On which exchange is FLKS stock listed?
FLKS stock is listed on the Nasdaq exchange.
What is Flexpharma Inc. worth?
Flexpharma Inc. (FLKS) has a market capitalization of 10.96M null. This makes FLKS a Nano Cap stock.
What are the support and resistance levels for Flexpharma Inc. (FLKS) stock?
Flexpharma Inc. (FLKS) has a support level at 0.6. Check the full technical report for a detailed analysis of FLKS support and resistance levels.
Should I buy Flexpharma Inc. (FLKS) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of FLKS, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of FLKS, evaluating the profitability, health, valuation and growth aspects
- Flexpharma Inc. (FLKS) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- Flexpharma Inc. (FLKS) Sales and EPS estimates to see what analysts future expectations are.
- Flexpharma Inc. (FLKS) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- Flexpharma Inc. (FLKS) Insider and Institutional Ownership to learn about the owners and their transactions.
- Flexpharma Inc. (FLKS) Stock Chart to make your own analysis
- Flexpharma Inc. (FLKS) Latest news and press-releases to stay up to date.
Does Flexpharma Inc. (FLKS) stock pay dividends?
FLKS does not pay a dividend.
What is the Price/Earnings (PE) ratio of Flexpharma Inc. (FLKS)?
Flexpharma Inc. (FLKS) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.88).
FLKS Technical Analysis
ChartMill assigns a technical rating of 5 / 10 to FLKS. When comparing the yearly performance of all stocks, FLKS is a bad performer in the overall market: 69.29% of all stocks are doing better.
FLKS Fundamental Analysis
ChartMill assigns a fundamental rating of 3 / 10 to FLKS. While FLKS seems to be doing ok healthwise, there are quite some concerns on its profitability.
FLKS Financial Highlights
Over the last trailing twelve months FLKS reported a non-GAAP Earnings per Share(EPS) of -0.88. The EPS increased by 55.33% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | -1208.29% | ||
| ROA | -115.76% | ||
| ROE | -135.42% | ||
| Debt/Equity | 0 |